We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+13.44%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$329M
AUM Growth
+$94M
Cap. Flow
+$80.7M
Cap. Flow %
24.51%
Top 10 Hldgs %
27.28%
Holding
112
New
38
Increased
35
Reduced
8
Closed
25

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$7.49M
2
KTWO
K2M Group Holdings, Inc
KTWO
+$6.3M
3
SYK icon
Stryker
SYK
+$5.17M
4
MEDP icon
Medpace
MEDP
+$4.63M
5
ABT icon
Abbott
ABT
+$4.5M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$6.94M
2
BMY icon
Bristol-Myers Squibb
BMY
+$6.34M
3
UHS icon
Universal Health Services
UHS
+$5.36M
4
MCK icon
McKesson
MCK
+$5.13M
5
ACH
Accendra Health
ACH
+$4.16M

Sector Composition

Rank Sector Weight
1 Healthcare 62.31%
2 Financials 2.43%
3 Industrials 2.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MEDP icon
26
Medpace
MEDP
$16.8B
$4.73M 1.44%
+158,428
New +$4.63M
AVXS
27
DELISTED
AveXis, Inc. Common Stock
AVXS
$4.57M 1.39%
111,000
+60,200
+119% +$2.29M
THC icon
28
PUT
Tenet Healthcare
THC
$20.9B
$4.53M 1.38%
+200,000
New +$5.21M
XENT
29
DELISTED
Intersect ENT, Inc
XENT
$4.36M 1.32%
275,000
+60,000
+28% +$904K
ALNY icon
30
Alnylam Pharmaceuticals
ALNY
$29.4B
$4.18M 1.27%
+61,625
New +$4.35M
JAZZ icon
31
Jazz Pharmaceuticals
JAZZ
$16.1B
$4.12M 1.25%
33,936
+11,936
+54% +$1.61M
MOH icon
32
Molina Healthcare
MOH
$10.3B
$4.08M 1.24%
+70,000
New +$3.86M
ACAD icon
33
Acadia Pharmaceuticals
ACAD
$5.11B
$3.92M 1.19%
+123,066
New +$4.17M
ALR
34
DELISTED
Alere Inc
ALR
$3.89M 1.18%
+90,000
New +$3.67M
WMGI
35
DELISTED
Wright Medical Group Inc
WMGI
$3.8M 1.15%
155,000
-70,000
-31% -$1.61M
PEN icon
36
Penumbra
PEN
$12.9B
$3.8M 1.15%
+50,000
New +$3.45M
ABT icon
37
CALL
Abbott
ABT
$190B
$3.71M 1.13%
+87,700
New +$3.76M
GWPH
38
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.7M 1.12%
+27,855
New +$2.66M
AKRX
39
DELISTED
Akorn Inc
AKRX
$3.68M 1.12%
135,125
+64,125
+90% +$1.9M
ZLTQ
40
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$3.53M 1.07%
+90,000
New +$3.21M
IVC
41
DELISTED
Invacare Corporation
IVC
$3.46M 1.05%
310,000
+17,500
+6% +$211K
THC icon
42
CALL
Tenet Healthcare
THC
$20.9B
$3.4M 1.03%
+150,000
New +$3.9M
PBYI icon
43
Puma Biotechnology
PBYI
$456M
$3.29M 1%
+49,125
New +$2.48M
ARAY icon
44
Accuray
ARAY
$35.1M
$3.19M 0.97%
+500,000
New +$2.73M
HRC
45
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$3.1M 0.94%
50,000
+5,000
+11% +$282K
CYNO
46
DELISTED
Cynosure, Inc. Class A
CYNO
$3.06M 0.93%
60,000
– –
PODD icon
47
Insulet
PODD
$10B
$3.05M 0.93%
74,600
-70,900
-49% -$2.8M
OFIX icon
48
Orthofix Medical
OFIX
$429M
$2.99M 0.91%
+70,000
New +$3.12M
RARE icon
49
Ultragenyx Pharmaceutical
RARE
$2.66B
$2.82M 0.86%
+39,750
New +$2.54M
KITE
50
DELISTED
Kite Pharma, Inc.
KITE
$2.77M 0.84%
49,500
+12,250
+33% +$683K
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2016 Portfolio in Review

As of Q3 2016, Pura Vida Investments held 112 positions worth $329M, up 40% from $235M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Pura Vida Investments deployed $80.7M of net new capital in Q3 2016, opening 38 new positions and adding to 35 existing holdings. Its largest new stake was Novartis: 102,812 shares worth $7.27M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 63% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Insulet, an estimated $2.8M trimmed.

  • Pura Vida Investments's largest Q3 2016 buy was Novartis: 102,812 shares worth $7.27M.
  • Pura Vida Investments added most to Stryker in Q3 2016, an estimated $5.17M increase.
  • Pura Vida Investments's biggest Q3 2016 reduction was Insulet, cutting an estimated $2.8M.
  • Pura Vida Investments fully exited Medtronic in Q3 2016, selling an estimated $6.94M.
  • Pura Vida Investments's ten largest holdings make up 27% of its $329M portfolio in Q3 2016.
  • Pura Vida Investments opened 38 new positions and closed 25 in Q3 2016.
  • Pura Vida Investments's portfolio value rose 40% quarter-over-quarter to $329M.

Based on Pura Vida Investments's 13F filing for Q3 2016, filed 14 Nov 2016.